Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.01 billion.
Market Cap
1.12T
Revenue
110.01B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.53%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.28B | 0.23% | 1,746,235 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 65.00B | -0.58% | 995,023 | 14.92B |
| 3 | ARGX | argenx SE | 50.57B | -1.20% | 171,180 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.71B | -1.02% | 681,263 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.49B | 0.20% | 190,918 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.22B | -1.41% | 1,935,089 | - |
| 7 | RPRX | Royalty Pharma plc | 31.38B | 1.77% | 3,053,570 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.30B | 1.33% | 668,712 | 3.23B |
| 9 | INSM | Insmed Incorporated | 23.03B | -3.00% | 2,432,851 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 21.55B | -2.98% | 5,874,354 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.41B | -0.26% | 879,786 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.60B | -0.80% | 4,223,677 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.43B | -0.65% | 1,205,395 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.34B | -0.19% | 450,896 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.05B | 0.18% | 550,091 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.54B | -1.65% | 1,826,350 | 579.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.90B | -4.87% | 6,890,997 | - |
| 18 | EXEL | Exelixis, Inc. | 12.61B | 1.01% | 1,543,918 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.49B | -0.29% | 1,579,157 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.14B | 1.00% | 674,563 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 0.71% | 160,811 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.56B | -0.78% | 1,401,609 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.45B | -0.02% | 2,438,349 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 10.45B | -1.43% | 1,111,296 | 105.82M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.79B | -1.64% | 1,178,752 | 5.67M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.58B | -2.00% | 249,964 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.83B | -1.57% | 162,207 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -0.29% | 1,197,479 | 1.51B |
| 29 | NUVL | Nuvalent, Inc. | 8.07B | 0.87% | 568,608 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.56B | -6.72% | 17,938,927 | 140.98M |
| 31 | TECH | Bio-Techne Corporation | 7.55B | 1.77% | 2,518,632 | 1.21B |
| 32 | IMVT | Immunovant, Inc. | 7.01B | 0.06% | 1,685,459 | - |
| 33 | PCVX | Vaxcyte, Inc. | 6.83B | -0.19% | 1,328,269 | - |
| 34 | CELC | Celcuity Inc. | 6.74B | -3.02% | 661,182 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.49B | -2.13% | 549,365 | 51.48M |
| 36 | CORT | Corcept Therapeutics Incorporated | 6.46B | 0.89% | 536,139 | 769.10M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.43B | -0.36% | 574,913 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -2.76% | 393,875 | 74.06M |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.15% | 707,486 | 15.00M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.08B | -1.68% | 338,285 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | -2.64% | 419,924 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.01B | -2.04% | 453,049 | 569.61M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.77B | 0.86% | 852,216 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.71B | -1.40% | 715,120 | 827.11M |
| 45 | CGON | CG Oncology, Inc. | 5.67B | -0.71% | 644,203 | 5.07M |
| 46 | COGT | Cogent Biosciences, Inc. | 5.58B | 0.28% | 1,966,915 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.51B | -0.94% | 1,358,447 | 700.35M |
| 48 | LEGN | Legend Biotech Corporation | 5.46B | 4.93% | 2,049,729 | 1.14B |
| 49 | BLTE | Belite Bio, Inc | 5.40B | -4.82% | 107,734 | - |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.24B | 0.09% | 969,842 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.86B | 0.92% | 1,550,762 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.73B | -3.51% | 469,756 | 1.34M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.60B | 3.22% | 368,352 | 274.48M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.40B | -2.45% | 1,808,949 | 907.29M |
| 55 | MANE | Veradermics, Incorporated | 4.19B | -2.94% | 278,729 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.14B | -0.84% | 583,591 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.13B | -0.69% | 803,359 | 536.20M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -0.81% | 702,431 | 18.07M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.06% | 1,993,230 | 596.96M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.66B | 3.27% | 1,101,788 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.61B | -1.03% | 1,376,979 | 1.10B |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.59B | 0.68% | 1,222,809 | - |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | 0.03% | 681,406 | - |
| 64 | ERAS | Erasca, Inc. | 3.50B | -3.19% | 2,494,052 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.22B | -7.79% | 258,615 | 803.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 2.96B | -3.42% | 3,554,640 | - |
| 67 | RLAY | Relay Therapeutics, Inc. | 2.95B | -0.95% | 5,355,060 | 10.68M |
| 68 | RCUS | Arcus Biosciences, Inc. | 2.95B | -1.84% | 516,535 | 236.00M |
| 69 | TNGX | Tango Therapeutics, Inc. | 2.93B | -6.38% | 1,651,342 | 56.99M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.87B | - | 1,447,960 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 2.85B | 3.51% | 1,327,347 | 164.01M |
| 72 | ALMS | Alumis Inc. | 2.81B | -0.68% | 567,254 | 8.40M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.79B | 1.03% | 729,871 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.74B | 0.43% | 341,294 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.68B | -1.92% | 259,588 | 535.08M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.61B | -0.71% | 1,162,971 | 415.62M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -1.49% | 450,525 | 225.27M |
| 78 | IRON | Disc Medicine, Inc. | 2.55B | -0.46% | 342,496 | - |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.53B | -1.68% | 632,207 | - |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.46B | -1.26% | 786,960 | - |
| 81 | DFTX | Definium Therapeutics, Inc. | 2.45B | -0.66% | 1,277,698 | - |
| 82 | IMNM | Immunome, Inc. | 2.45B | -5.66% | 1,027,175 | 4.02M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.44B | -0.90% | 448,580 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.41B | 0.49% | 582,806 | 865.00K |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.30B | -1.35% | 1,130,358 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.26B | -3.15% | 500,620 | - |
| 87 | NKTR | Nektar Therapeutics | 2.25B | -2.87% | 533,806 | 55.63M |
| 88 | ZLAB | Zai Lab Limited | 2.09B | -2.54% | 389,980 | 453.28M |
| 89 | PHVS | Pharvaris N.V. | 2.07B | -2.82% | 291,071 | - |
| 90 | NBTX | Nanobiotix S.A. | 2.05B | 2.07% | 54,866 | 38.27M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 2.01B | -0.21% | 1,323,227 | - |
| 92 | MESO | Mesoblast Limited | 1.96B | 1.47% | 115,563 | 65.38M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -1.49% | 994,130 | 298.30M |
| 94 | AAPG | Ascentage Pharma Group International | 1.96B | 1.69% | 8,252 | 82.08M |
| 95 | TYRA | Tyra Biosciences, Inc. | 1.93B | -1.67% | 312,023 | - |
| 96 | ADMA | ADMA Biologics, Inc. | 1.91B | -2.60% | 2,973,292 | 509.86M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.90B | -2.54% | 2,860,149 | 70.92M |
| 98 | ZYME | Zymeworks Inc. | 1.87B | 1.99% | 477,949 | 81.26M |
| 99 | GENB | Generate Biomedicines, Inc. | 1.86B | 3.93% | 784,593 | 30.30M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.86B | -1.49% | 171,395 | - |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 1.84B | 11.08% | 23,088,612 | 285.61M |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.83B | -1.11% | 682,756 | 32.08M |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -1.03% | 123,617 | 1.20B |
| 104 | NRIX | Nurix Therapeutics, Inc. | 1.81B | -0.17% | 1,053,788 | 71.78M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 1.80B | 2.78% | 174,249 | 20.00M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.80B | 0.12% | 2,032,363 | 52.04M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | -0.94% | 1,959,125 | 2.18B |
| 108 | VCEL | Vericel Corporation | 1.77B | -1.19% | 383,595 | 292.09M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 0.86% | 1,146,122 | 217.17M |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 1.86% | 3,198,831 | 66.09M |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -1.12% | 431,486 | 899.11M |
| 112 | OCS | Oculis Holding AG | 1.74B | -4.87% | 487,736 | 1.40M |
| 113 | ANAB | AnaptysBio, Inc. | 1.74B | -1.16% | 408,620 | 232.39M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | -2.26% | 874,381 | 66.05M |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.67B | -2.40% | 569,841 | 11.13M |
| 116 | INVA | Innoviva, Inc. | 1.66B | 1.17% | 1,187,316 | 420.69M |
| 117 | NUVB | Nuvation Bio Inc. | 1.64B | -1.46% | 4,196,784 | 143.05M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.63B | -1.66% | 146,366 | - |
| 119 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | -3.22% | 14,023,299 | 66.41M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | -0.37% | 906,671 | 42.95M |
| 121 | ABCL | AbCellera Biologics Inc. | 1.59B | 1.17% | 6,465,963 | 79.21M |
| 122 | ATAI | AtaiBeckley Inc. | 1.59B | -0.23% | 5,017,530 | 3.49M |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | -0.90% | 1,656,371 | 7.47M |
| 124 | IMTX | Immatics N.V. | 1.56B | 5.06% | 461,705 | 43.00M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.56B | 1.77% | 166,300 | - |
| 126 | VIR | Vir Biotechnology, Inc. | 1.55B | 1.77% | 1,208,981 | 65.50M |
| 127 | QURE | uniQure N.V. | 1.53B | -2.30% | 680,408 | 18.09M |
| 128 | GHRS | GH Research PLC | 1.52B | 1.61% | 351,017 | - |
| 129 | MBX | MBX Biosciences, Inc. | 1.52B | 0.19% | 436,076 | - |
| 130 | NVAX | Novavax, Inc. | 1.51B | 2.56% | 4,434,613 | 596.34M |
| 131 | PGEN | Precigen, Inc. | 1.51B | -0.93% | 1,712,966 | 31.60M |
| 132 | ARDX | Ardelyx, Inc. | 1.51B | -3.78% | 2,321,916 | 427.68M |
| 133 | INBX | Inhibrx Biosciences, Inc. | 1.49B | -8.37% | 553,012 | 1.30M |
| 134 | IMCR | Immunocore Holdings plc | 1.47B | -3.90% | 689,630 | 412.81M |
| 135 | SLS | SELLAS Life Sciences Group, Inc. | 1.45B | 2.91% | 10,700,301 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.43B | 0.12% | 405,302 | 20.00M |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.07% | 1,565,725 | 114.48M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.42B | 4.03% | 365,780 | - |
| 139 | BHVN | Biohaven Ltd. | 1.42B | -0.32% | 1,436,991 | - |
| 140 | URGN | UroGen Pharma Ltd. | 1.41B | -3.31% | 364,372 | 140.49M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.33B | -1.52% | 653,756 | - |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -1.81% | 164,135 | - |
| 143 | SEPN | Septerna, Inc. | 1.28B | 1.58% | 346,804 | 72.26M |
| 144 | SVRA | Savara Inc. | 1.27B | -0.79% | 668,270 | - |
| 145 | FTRE | Fortrea Holdings Inc. | 1.25B | 0.61% | 924,137 | 2.71B |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.24B | -1.00% | 434,859 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.23B | -0.62% | 2,386,400 | 71.80M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.21B | 1.51% | 321,470 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.20B | -4.39% | 342,227 | 10.00M |
| 150 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -2.70% | 1,067,375 | - |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | -1.56% | 135,225 | - |
| 152 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.14B | -1.79% | 2,235,591 | 204.73M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.12B | 6.38% | 129,683 | 8.28M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.10B | -5.33% | 372,118 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.09B | -2.10% | 93,032 | 5.74M |
| 156 | EYPT | EyePoint, Inc. | 1.08B | 1.17% | 783,848 | 7.61M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | -3.59% | 1,180,562 | - |
| 158 | IVA | Inventiva S.A. | 1.06B | -2.69% | 185,067 | 7.94M |
| 159 | MNKD | MannKind Corporation | 1.04B | 2.11% | 4,608,165 | 360.78M |
| 160 | KURA | Kura Oncology, Inc. | 998.71M | 1.08% | 2,488,755 | 71.64M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 959.26M | -3.14% | 1,625,106 | 69.64M |
| 162 | SPTX | Seaport Therapeutics, Inc. | 927.99M | 1.80% | 214,579 | - |
| 163 | PHAR | Pharming Group N.V. | 915.89M | -1.64% | 24,503 | 369.49M |
| 164 | DRTS | Alpha Tau Medical Ltd. | 905.37M | -8.39% | 857,991 | - |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 899.94M | -2.16% | 759,657 | 204.89M |
| 166 | JANX | Janux Therapeutics, Inc. | 885.49M | 0.76% | 436,399 | 13.73M |
| 167 | ANNX | Annexon, Inc. | 870.00M | -2.39% | 2,180,097 | - |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 861.27M | -1.65% | 795,218 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 859.29M | -2.03% | 847,286 | 191.45M |
| 170 | MGTX | MeiraGTx Holdings plc | 855.71M | -2.63% | 383,903 | 79.76M |
| 171 | SANA | Sana Biotechnology, Inc. | 854.36M | -2.54% | 4,191,412 | - |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 850.58M | -1.00% | 471,167 | - |
| 173 | TBPH | Theravance Biopharma, Inc. | 843.92M | 0.18% | 277,609 | 109.78M |
| 174 | XNCR | Xencor, Inc. | 838.54M | 0.35% | 522,183 | 97.36M |
| 175 | AURA | Aura Biosciences, Inc. | 838.28M | -0.65% | 278,175 | - |
| 176 | OMER | Omeros Corporation | 829.42M | -4.18% | 1,525,751 | 9.89M |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 825.55M | -1.35% | 323,581 | 2.98M |
| 178 | DRUG | Bright Minds Biosciences Inc. | 825.09M | 0.31% | 281,058 | - |
| 179 | EVMN | Evommune, Inc. | 823.74M | -2.89% | 376,663 | 10.00M |
| 180 | GERN | Geron Corporation | 821.15M | 1.59% | 6,867,345 | 196.12M |
| 181 | CTMX | CytomX Therapeutics, Inc. | 818.56M | - | 2,047,154 | 35.54M |
| 182 | LBRX | LB Pharmaceuticals Inc | 806.39M | 0.43% | 145,378 | - |
| 183 | AVTX | Avalo Therapeutics, Inc. | 802.07M | -1.51% | 1,317,318 | 59.00K |
| 184 | ABSI | Absci Corporation | 795.12M | 0.20% | 2,242,609 | 1.84M |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 788.47M | -3.52% | 2,485,990 | 98.99M |
| 186 | VOR | Vor Biopharma Inc. | 776.48M | -4.72% | 728,620 | - |
| 187 | ANRO | Alto Neuroscience, Inc. | 743.82M | -1.49% | 271,396 | - |
| 188 | RLMD | Relmada Therapeutics, Inc. | 738.41M | -2.36% | 668,681 | - |
| 189 | TENX | Tenax Therapeutics, Inc. | 714.19M | -1.86% | 219,568 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 696.61M | -5.49% | 107,169 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 690.31M | 2.04% | 4,127,266 | 22.00K |
| 192 | CBIO | Crescent Biopharma, Inc. | 689.17M | 2.52% | 140,396 | 11.88M |
| 193 | DSGN | Design Therapeutics, Inc. | 685.15M | -0.36% | 1,040,814 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 684.28M | -6.15% | 747,123 | - |
| 195 | SLDB | Solid Biosciences Inc. | 651.74M | 1.85% | 969,307 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | -0.44% | 627,674 | 8.37M |
| 197 | CRMD | CorMedix Inc. | 626.05M | -0.99% | 826,220 | 400.05M |
| 198 | IMMX | Immix Biopharma, Inc. | 612.76M | 1.27% | 2,528,754 | - |
| 199 | TRAX | First Tracks Biotherapeutics, Inc. | 599.45M | 2.51% | 318,536 | - |
| 200 | CABA | Cabaletta Bio, Inc. | 595.15M | -1.08% | 2,243,396 | - |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 592.92M | -4.39% | 1,364,538 | 122.29M |
| 202 | EIKN | Eikon Therapeutics, Inc. | 590.65M | -2.24% | 223,685 | - |
| 203 | ARVN | Arvinas, Inc. | 586.50M | -0.11% | 778,412 | 89.40M |
| 204 | CADL | Candel Therapeutics, Inc. | 585.43M | 0.76% | 1,588,853 | - |
| 205 | AGMB | AgomAb Therapeutics NV | 566.35M | 5.30% | 34,113 | - |
| 206 | ALT | Altimmune, Inc. | 563.98M | -1.02% | 1,989,244 | 36.00K |
| 207 | GYRE | Gyre Therapeutics, Inc. | 553.71M | -1.94% | 86,955 | 117.05M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 549.47M | 2.00% | 109,612 | - |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 549.38M | 4.08% | 875,216 | 151.40M |
| 210 | ASMB | Assembly Biosciences, Inc. | 545.58M | 6.94% | 958,890 | 71.10M |
| 211 | VALN | Valneva SE | 544.46M | 1.02% | 75,713 | 180.25M |
| 212 | MDXG | MiMedx Group, Inc. | 539.18M | 0.28% | 815,625 | 389.42M |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 536.75M | -0.62% | 183,367 | 299.77M |
| 214 | PRME | Prime Medicine, Inc. | 536.43M | 0.68% | 2,273,184 | 4.03M |
| 215 | PROK | ProKidney Corp. | 528.60M | - | 479,725 | 889.00K |
| 216 | FBRX | Forte Biosciences, Inc. | 527.57M | -2.07% | 123,967 | - |
| 217 | CLYM | Climb Bio, Inc. | 525.45M | 0.82% | 454,793 | - |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 524.80M | -2.58% | 499,406 | - |
| 219 | XOMA | XOMA Royalty Corporation | 522.33M | -0.41% | 124,828 | 48.56M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 518.18M | -3.34% | 220,301 | - |
| 221 | PRTA | Prothena Corporation plc | 514.63M | 4.46% | 510,853 | 57.94M |
| 222 | ACHV | Achieve Life Sciences, Inc. | 481.47M | 1.96% | 816,594 | - |
| 223 | ANL | Adlai Nortye Ltd. | 476.80M | 2.55% | 24,218 | 5.00M |
| 224 | STTK | Shattuck Labs, Inc. | 467.75M | 0.16% | 338,676 | 1.00M |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 458.60M | 2.31% | 903,390 | - |
| 226 | UPB | Upstream Bio, Inc. | 455.50M | -1.06% | 354,422 | 3.32M |
| 227 | OCGN | Ocugen, Inc. | 453.62M | -0.74% | 3,936,042 | 4.47M |
| 228 | AUTL | Autolus Therapeutics plc | 452.44M | 3.03% | 1,043,463 | 92.62M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 449.58M | -1.04% | 503,989 | 88.24M |
| 230 | NGNE | Neurogene Inc. | 437.87M | 0.36% | 84,710 | 925.00K |
| 231 | SGMT | Sagimet Biosciences Inc. | 437.82M | 1.29% | 956,492 | - |
| 232 | FULC | Fulcrum Therapeutics, Inc. | 437.78M | -0.30% | 306,212 | 80.00M |
| 233 | ADCT | ADC Therapeutics SA | 431.18M | -0.29% | 648,497 | 79.18M |
| 234 | PRLD | Prelude Therapeutics Incorporated | 429.47M | -1.39% | 241,676 | 16.72M |
| 235 | OVID | Ovid Therapeutics Inc. | 427.40M | 1.23% | 1,339,246 | 7.12M |
| 236 | VTVT | vTv Therapeutics Inc. | 426.95M | -3.08% | 60,552 | 36.84M |
| 237 | STRO | Sutro Biopharma, Inc. | 423.64M | -16.49% | 708,055 | 99.61M |
| 238 | MNPR | Monopar Therapeutics Inc. | 422.83M | 0.70% | 92,183 | - |
| 239 | ZURA | Zura Bio Limited | 413.68M | -1.80% | 510,979 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 407.60M | -0.44% | 531,880 | 109.16M |
| 241 | LYEL | Lyell Immunopharma, Inc. | 407.41M | 0.84% | 54,335 | 31.00K |
| 242 | ENTA | Enanta Pharmaceuticals, Inc. | 405.64M | 0.94% | 141,313 | 69.21M |
| 243 | REPL | Replimune Group, Inc. | 405.43M | -5.94% | 2,957,749 | - |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 401.25M | -2.29% | 461,190 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 392.24M | 1.14% | 1,707,828 | 34.86M |
| 246 | BNTC | Benitec Biopharma Inc. | 385.80M | -0.79% | 100,508 | - |
| 247 | IFRX | InflaRx N.V. | 384.43M | 5.67% | 1,507,467 | 33.82K |
| 248 | OABI | OmniAb, Inc. | 384.18M | 3.92% | 711,933 | 28.94M |
| 249 | GLSI | Greenwich LifeSciences, Inc. | 383.08M | 1.69% | 78,133 | - |
| 250 | ARTV | Artiva Biotherapeutics, Inc. | 382.39M | -1.50% | 308,799 | 251.00K |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 381.05M | - | 177,820 | 9.01M |
| 252 | CMPX | Compass Therapeutics, Inc. | 372.78M | 7.25% | 5,945,503 | 850.00K |
| 253 | VSTM | Verastem, Inc. | 372.58M | -0.70% | 1,608,366 | 49.59M |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 372.24M | -0.32% | 884,173 | 217.78M |
| 255 | PBYI | Puma Biotechnology, Inc. | 360.37M | 0.43% | 187,001 | 227.18M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 360.12M | -3.36% | 1,126,324 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 353.72M | 4.25% | 356,215 | - |
| 258 | IMRX | Immuneering Corporation | 348.72M | 3.26% | 10,176,981 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 344.94M | -0.40% | 194,341 | 51.00M |
| 260 | RZLT | Rezolute, Inc. | 339.52M | -2.69% | 814,424 | - |
| 261 | NMRA | Neumora Therapeutics, Inc. | 337.97M | - | 1,362,265 | - |
| 262 | YDES | YD Bio Limited | 334.02M | 5.09% | 4,457 | 510.36K |
| 263 | RGNX | REGENXBIO Inc. | 328.28M | -5.93% | 1,569,331 | 87.82M |
| 264 | PALI | Palisade Bio, Inc. | 326.48M | -2.99% | 3,260,517 | - |
| 265 | LCTX | Lineage Cell Therapeutics, Inc. | 324.09M | -1.52% | 788,034 | 14.78M |
| 266 | IVVD | Invivyd, Inc. | 324.07M | -0.90% | 1,813,315 | 55.87M |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 323.21M | -4.82% | 2,111,680 | - |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 322.78M | - | 363,054 | - |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 318.45M | 2.43% | 87,853 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 317.17M | 2.25% | 304,064 | 63.50M |
| 271 | ABEO | Abeona Therapeutics Inc. | 310.05M | -1.45% | 671,998 | 14.54M |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 306.77M | 1.58% | 41,798 | 5.20M |
| 273 | SRZN | Surrozen, Inc. | 306.17M | -2.66% | 52,973 | 7.49M |
| 274 | IRD | Opus Genetics, Inc. | 304.17M | -0.70% | 569,453 | 11.98M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 300.71M | - | 666,644 | - |
| 276 | SLN | Silence Therapeutics plc | 292.85M | -4.47% | 258,019 | 839.00K |
| 277 | NAGE | Niagen Bioscience, Inc. | 292.11M | -3.43% | 730,299 | 130.42M |
| 278 | ZNTL | Zentalis Pharmaceuticals, Inc. | 289.02M | -1.93% | 546,934 | 26.87M |
| 279 | IKT | Inhibikase Therapeutics, Inc. | 288.01M | -2.87% | 512,162 | 1.00 |
| 280 | MGNX | MacroGenics, Inc. | 287.93M | 6.84% | 1,104,164 | 157.08M |
| 281 | ACIU | AC Immune SA | 280.74M | -0.70% | 78,141 | 4.62M |
| 282 | TARA | Protara Therapeutics, Inc. | 276.52M | -1.01% | 1,130,340 | - |
| 283 | NVCT | Nuvectis Pharma, Inc. | 274.54M | -5.39% | 157,224 | - |
| 284 | SABS | SAB Biotherapeutics, Inc. | 274.08M | 2.36% | 326,176 | 114.70K |
| 285 | EDIT | Editas Medicine, Inc. | 270.22M | 3.37% | 1,021,334 | 38.69M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 266.43M | -0.50% | 1,167,937 | - |
| 287 | CGEN | Compugen Ltd. | 264.84M | 7.28% | 580,140 | 72.66M |
| 288 | FATE | Fate Therapeutics, Inc. | 262.26M | 7.14% | 5,904,958 | 6.32M |
| 289 | CLLS | Cellectis S.A. | 258.00M | -0.57% | 13,500 | 75.11M |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 250.83M | 12.33% | 76,841 | 19.39M |
| 291 | AVXL | Anavex Life Sciences Corp. | 249.75M | -0.55% | 1,119,999 | - |
| 292 | CHRS | Coherus Oncology, Inc. | 248.34M | 2.55% | 919,436 | 46.88M |
| 293 | FHTX | Foghorn Therapeutics Inc. | 247.77M | 1.44% | 164,704 | 28.22M |
| 294 | ADAG | Adagene Inc. | 247.77M | -1.06% | 69,403 | 7.67M |
| 295 | ALEC | Alector, Inc. | 245.37M | - | 328,072 | 18.42M |
| 296 | NERV | Minerva Neurosciences, Inc. | 245.06M | -0.75% | 83,997 | - |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 243.12M | -1.22% | 198,200 | 32.72M |
| 298 | CNTX | Context Therapeutics Inc. | 238.89M | 8.33% | 1,916,218 | - |
| 299 | LENZ | LENZ Therapeutics, Inc. | 236.73M | 0.40% | 566,725 | 20.99M |
| 300 | TRDA | Entrada Therapeutics, Inc. | 236.38M | 3.96% | 369,793 | 5.74M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 234.19M | 2.27% | 76,188 | 3.93M |
| 302 | HELP | Cybin Inc. | 234.17M | 1.74% | 592,803 | - |
| 303 | HUMA | Humacyte, Inc. | 233.12M | 2.94% | 3,766,260 | 2.02M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 229.60M | 3.26% | 571,581 | 36.49M |
| 305 | CDXS | Codexis, Inc. | 226.33M | -1.58% | 865,787 | 78.09M |
| 306 | RNA | Atrium Therapeutics, Inc. | 223.91M | 0.23% | 292,222 | 36.68M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 221.93M | 4.42% | 347,099 | 7.15M |
| 308 | KROS | Keros Therapeutics, Inc. | 221.47M | -0.27% | 271,062 | 33.18M |
| 309 | NKTX | Nkarta, Inc. | 216.78M | - | 357,114 | - |
| 310 | UNCY | Unicycive Therapeutics, Inc. | 215.74M | 5.90% | 591,938 | - |
| 311 | MDWD | MediWound Ltd. | 213.09M | -1.54% | 21,920 | 16.96M |
| 312 | CRBU | Caribou Biosciences, Inc. | 206.34M | 5.53% | 1,396,555 | 11.20M |
| 313 | NBP | NovaBridge Biosciences | 204.70M | -0.56% | 809,917 | - |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.56M | -8.79% | 622,014 | 17.56M |
| 315 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 201.31M | -1.39% | 556,436 | - |
| 316 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.81M | 0.14% | 266,400 | 54.71M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 199.43M | 5.07% | 610,958 | - |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 198.33M | 1.20% | 109,017 | 1.78M |
| 319 | MIST | Milestone Pharmaceuticals Inc. | 191.83M | -7.24% | 1,253,843 | 1.78M |
| 320 | TLSA | Tiziana Life Sciences Ltd | 188.88M | 1.37% | 576,478 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 186.55M | 1.12% | 179,868 | 45.07M |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 184.02M | 1.24% | 294,996 | 151.12M |
| 323 | ELTX | Elicio Therapeutics, Inc. | 183.04M | 0.51% | 111,351 | - |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 181.29M | 0.80% | 396,451 | - |
| 325 | IPHA | Innate Pharma S.A. | 178.49M | -7.11% | 14,901 | 10.57M |
| 326 | IMUX | Immunic, Inc. | 177.76M | 6.10% | 327,029 | - |
| 327 | ANTX | AN2 Therapeutics, Inc. | 174.58M | -0.82% | 731,434 | - |
| 328 | ENLV | Enlivex Ltd. | 172.95M | -0.37% | 111,980 | - |
| 329 | PLYX | Polaryx Therapeutics, Inc. | 170.44M | -8.63% | 174,353 | - |
| 330 | OKUR | OnKure Therapeutics, Inc. | 170.06M | 3.44% | 250,307 | - |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 169.20M | 3.45% | 714,016 | 76.38M |
| 332 | NGEN | NervGen Pharma Corp. | 168.34M | -43.48% | 12,434,005 | - |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 167.63M | -2.22% | 1,635,550 | 225.00K |
| 334 | KRRO | Korro Bio, Inc. | 167.45M | 3.66% | 231,153 | 3.84M |
| 335 | GALT | Galectin Therapeutics Inc. | 164.64M | -0.79% | 302,679 | - |
| 336 | PRQR | ProQR Therapeutics N.V. | 164.37M | 8.33% | 552,639 | 15.73M |
| 337 | HRTX | Heron Therapeutics, Inc. | 162.55M | -1.42% | 1,049,775 | 150.71M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 161.38M | -8.90% | 155,561 | 2.00M |
| 339 | SPRO | Spero Therapeutics, Inc. | 159.81M | 2.60% | 545,468 | 61.19M |
| 340 | MENS | Jyong Biotech Ltd. | 159.60M | 3.37% | 45,050 | - |
| 341 | HURA | TuHURA Biosciences, Inc. | 159.21M | 6.84% | 642,714 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 156.09M | 3.72% | 156,098 | 1.27M |
| 343 | TTRX | Turn Therapeutics Inc. | 152.81M | 3.22% | 33,208 | - |
| 344 | MOLN | Molecular Partners AG | 149.98M | 10.00% | 10,796 | 856.30K |
| 345 | GUTS | Fractyl Health, Inc. | 144.31M | -1.13% | 1,888,316 | 3.00K |
| 346 | EQ | Equillium, Inc. | 142.89M | 2.26% | 467,385 | 4.39M |
| 347 | INDP | Indaptus Therapeutics, Inc. | 138.16M | 15.09% | 200,297 | - |
| 348 | SPRB | Spruce Biosciences, Inc. | 138.02M | -3.08% | 71,762 | 697.00K |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 135.19M | 1.12% | 82,013 | 39.99K |
| 350 | CNTB | Connect Biopharma Holdings Limited | 132.83M | -0.42% | 94,536 | 233.00K |
| 351 | BDTX | Black Diamond Therapeutics, Inc. | 130.65M | -35.77% | 8,382,098 | 70.00M |
| 352 | GNLX | Genelux Corporation | 129.67M | - | 76,801 | 8.00K |
| 353 | AGEN | Agenus Inc. | 129.18M | -1.58% | 901,310 | 123.87M |
| 354 | ACOG | Alpha Cognition Inc. | 127.38M | 0.52% | 31,427 | 10.83M |
| 355 | PYXS | Pyxis Oncology, Inc. | 124.18M | 1.03% | 1,215,485 | 13.86M |
| 356 | CRDF | Cardiff Oncology, Inc. | 121.70M | -0.56% | 1,262,718 | 525.00K |
| 357 | NRXP | NRx Pharmaceuticals, Inc. | 116.55M | 5.23% | 1,484,089 | 2.29M |
| 358 | KLRS | Kalaris Therapeutics, Inc. | 113.12M | -3.91% | 88,981 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 112.83M | -0.62% | 75,959 | 7.94M |
| 360 | CGTX | Cognition Therapeutics, Inc. | 112.59M | 0.80% | 531,681 | - |
| 361 | ALPS | Alps Group Inc | 112.05M | -3.80% | 53,259 | 3.74M |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 110.62M | 1.50% | 3,320,302 | 65.34K |
| 363 | ENGN | enGene Therapeutics Inc. | 109.86M | -5.20% | 1,267,377 | - |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 106.80M | - | 764,275 | 3.17M |
| 365 | CBUS | Cibus, Inc. | 105.27M | - | 285,418 | 4.29M |
| 366 | PEPG | PepGen Inc. | 104.45M | -1.95% | 569,697 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 104.10M | 2.71% | 71,894 | 37.16M |
| 368 | VANI | Vivani Medical, Inc. | 103.48M | 3.45% | 389,482 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 102.67M | 3.65% | 910,904 | - |
| 370 | SEER | Seer, Inc. | 100.99M | 1.13% | 559,403 | 15.17M |
| 371 | AARD | Aardvark Therapeutics, Inc. | 99.05M | 0.67% | 136,833 | - |
| 372 | PMN | ProMIS Neurosciences, Inc. | 98.47M | 1.20% | 29,371 | - |
| 373 | QTTB | Q32 Bio Inc. | 98.35M | 5.45% | 629,071 | 53.74M |
| 374 | LONA | LeonaBio, Inc. | 97.04M | 4.32% | 22,984 | - |
| 375 | RNTX | Rein Therapeutics Inc. | 95.83M | -0.96% | 390,002 | - |
| 376 | PYPD | PolyPid Ltd. | 95.80M | 3.93% | 198,756 | - |
| 377 | ANVS | Annovis Bio, Inc. | 94.87M | 3.72% | 2,606,595 | - |
| 378 | ONCY | Oncolytics Biotech Inc. | 94.01M | 2.47% | 566,339 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 93.54M | 1.45% | 40,487 | - |
| 380 | ALDX | Aldeyra Therapeutics, Inc. | 93.50M | -2.52% | 475,196 | - |
| 381 | EDSA | Edesa Biotech, Inc. | 92.94M | -3.77% | 114,892 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 92.66M | -1.62% | 12,395 | 27.70M |
| 383 | ICCC | ImmuCell Corporation | 91.55M | 1.50% | 33,470 | 29.93M |
| 384 | FBIO | Fortress Biotech, Inc. | 91.02M | -1.44% | 305,115 | 66.16M |
| 385 | ACET | Adicet Bio, Inc. | 87.16M | 5.20% | 92,027 | - |
| 386 | OKYO | OKYO Pharma Limited | 85.54M | -2.98% | 49,284 | - |
| 387 | HYFT | MindWalk Holdings Corp. | 84.93M | 11.04% | 1,736,463 | 20.70M |
| 388 | NRXS | NeurAxis, Inc. | 84.91M | -0.67% | 95,356 | 4.28M |
| 389 | EXOZ | eXoZymes, Inc. | 84.11M | 5.53% | 17,597 | -700.00 |
| 390 | RLYB | Rallybio Corporation | 84.00M | 3.25% | 64,979 | 858.00K |
| 391 | CSBR | Champions Oncology, Inc. | 83.46M | -1.68% | 9,298 | 57.95M |
| 392 | ATRA | Atara Biotherapeutics, Inc. | 83.42M | 4.93% | 125,047 | 23.14M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 77.82M | - | 271,602 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 77.52M | -0.96% | 37,218 | 4.43M |
| 395 | MCRB | Seres Therapeutics, Inc. | 76.70M | -1.61% | 21,028 | 1.15M |
| 396 | GANX | Gain Therapeutics, Inc. | 75.92M | 1.71% | 413,146 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 74.92M | -1.63% | 212,116 | - |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 74.90M | -2.23% | 825,777 | - |
| 399 | XBIT | XBiotech Inc. | 74.09M | -1.21% | 13,747 | - |
| 400 | OSTX | OS Therapies Incorporated | 72.73M | -4.95% | 340,079 | - |
| 401 | CUE | Cue Biopharma, Inc. | 69.89M | 6.82% | 61,162 | 32.73M |
| 402 | TCRX | TScan Therapeutics, Inc. | 69.27M | 3.92% | 676,320 | 9.14M |
| 403 | MNOV | MediciNova, Inc. | 68.91M | 2.19% | 12,741 | 596.64K |
| 404 | LIXT | Lixte Biotechnology Holdings, Inc. | 68.31M | -0.51% | 140,914 | - |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 67.20M | -1.56% | 163,285 | - |
| 406 | PDSB | PDS Biotechnology Corporation | 66.98M | 3.45% | 1,166,990 | - |
| 407 | IBIO | iBio, Inc. | 66.50M | -2.65% | 600,804 | 300.00K |
| 408 | BYSI | BeyondSpring Inc. | 64.56M | 9.03% | 40,074 | 1.88M |
| 409 | FLNA | Filana Therapeutics, Inc. | 63.28M | 1.55% | 233,660 | - |
| 410 | IMMP | Immutep Limited | 63.03M | 1.17% | 363,186 | 5.28M |
| 411 | IMA | ImageneBio, Inc. | 62.71M | 0.72% | 11,290 | 800.00K |
| 412 | ENTX | Entera Bio Ltd. | 61.04M | -2.36% | 26,442 | 42.00K |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 59.79M | -1.10% | 32,646 | - |
| 414 | CING | Cingulate Inc. | 59.34M | -5.70% | 486,279 | - |
| 415 | IBO | Impact BioMedical Inc. | 58.63M | 2.24% | 30,399 | 39.00K |
| 416 | ACTU | Actuate Therapeutics, Inc. | 56.94M | -1.65% | 57,534 | - |
| 417 | TIL | Instil Bio, Inc. | 55.48M | 0.74% | 17,872 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 54.15M | -0.64% | 41,783 | - |
| 419 | QNTM | Quantum BioPharma Ltd. | 53.96M | 18.31% | 833,836 | - |
| 420 | RADX | Radiopharm Theranostics Limited | 53.05M | 0.65% | 15,966 | 10.86M |
| 421 | HYPD | Hyperion DeFi, Inc. | 51.43M | -7.18% | 567,879 | 1.04M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 50.82M | 3.05% | 180,701 | 22.33M |
| 423 | ESLA | Estrella Immunopharma, Inc. | 49.49M | 2.65% | 28,050 | - |
| 424 | XLO | Xilio Therapeutics, Inc. | 49.36M | -3.50% | 58,469 | 53.48M |
| 425 | GOSS | Gossamer Bio, Inc. | 49.31M | 4.58% | 12,800,482 | 55.54M |
| 426 | ATYR | aTyr Pharma, Inc. | 48.05M | -7.28% | 3,186,024 | 190.00K |
| 427 | PSTV | Plus Therapeutics, Inc. | 45.22M | -4.35% | 128,165 | 5.18M |
| 428 | KALA | KALA BIO, Inc. | 45.17M | -6.54% | 60,398 | - |
| 429 | MREO | Mereo BioPharma Group plc | 44.42M | 2.28% | 1,910,744 | 500.00K |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | -0.77% | 53,956 | - |
| 431 | NTRB | Nutriband Inc. | 44.25M | 4.30% | 4,935 | 2.04M |
| 432 | ATOS | Atossa Therapeutics, Inc. | 42.71M | -0.20% | 28,196 | - |
| 433 | TVGN | Tevogen Bio Holdings Inc. | 40.24M | -16.94% | 46,934 | - |
| 434 | RNXT | RenovoRx, Inc. | 39.71M | -0.01% | 162,556 | 1.49M |
| 435 | LTRN | Lantern Pharma Inc. | 39.23M | 5.42% | 450,890 | - |
| 436 | LITS | Lite Strategy, Inc. | 38.91M | -2.73% | 882,423 | - |
| 437 | INMB | INmune Bio Inc. | 38.55M | 0.69% | 170,432 | 50.00K |
| 438 | VERU | Veru Inc. | 37.72M | 5.86% | 89,864 | 16.89M |
| 439 | OTLK | Outlook Therapeutics, Inc. | 37.46M | -6.94% | 11,015,036 | 333.14K |
| 440 | NNVC | NanoViricides, Inc. | 37.36M | 5.81% | 772,250 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | - | 73,385 | 90.00K |
| 442 | ALGS | Aligos Therapeutics, Inc. | 35.64M | 0.88% | 136,660 | 4.71M |
| 443 | DARE | Daré Bioscience, Inc. | 35.50M | -1.66% | 435,687 | 1.16M |
| 444 | GRCE | Grace Therapeutics, Inc. | 34.04M | -1.79% | 259,833 | - |
| 445 | EVAX | Evaxion A/S | 34.03M | 0.49% | 24,718 | 7.53M |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 33.49M | -0.56% | 48,508 | - |
| 447 | BOLD | Boundless Bio, Inc. | 32.28M | -0.69% | 72,830 | - |
| 448 | APLM | Apollomics, Inc. | 30.93M | -1.57% | 7,735 | 8.84M |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 30.74M | 0.28% | 156,126 | 38.00K |
| 450 | GRDX | GridAI Technologies Corp. | 30.01M | 4.99% | 182,772 | - |
| 451 | NEUP | Neuphoria Therapeutics Inc. | 29.62M | 7.03% | 141,920 | -13.27K |
| 452 | SER | Serina Therapeutics, Inc. | 29.50M | 4.93% | 199,353 | 130.00K |
| 453 | SKYE | Skye Bioscience, Inc. | 29.13M | 16.03% | 233,502 | - |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 28.99M | 6.08% | 66,930 | - |
| 455 | PLRZ | Polyrizon Ltd. | 28.56M | 20.59% | 47,034 | - |
| 456 | IGC | IGC Pharma, Inc. | 28.45M | -0.31% | 4,051,982 | 1.11M |
| 457 | LSTA | Lisata Therapeutics, Inc. | 28.36M | - | 1,986 | 170.00K |
| 458 | CRVO | CervoMed Inc. | 28.33M | -0.97% | 102,002 | 2.09M |
| 459 | KYNB | Kyntra Bio, Inc. | 28.30M | 0.72% | 11,628 | 7.44M |
| 460 | NXTC | NextCure, Inc. | 28.25M | -23.24% | 94,119 | - |
| 461 | ABVC | ABVC BioPharma, Inc. | 28.17M | 2.70% | 254,574 | 797.92K |
| 462 | BRNS | Barinthus Biotherapeutics plc | 28.06M | -1.98% | 7,974 | 14.97M |
| 463 | DYAI | Dyadic International, Inc. | 27.66M | 2.59% | 216,759 | 3.81M |
| 464 | ALLR | Allarity Therapeutics, Inc. | 27.37M | 6.63% | 312,476 | 345.00K |
| 465 | TPST | Tempest Therapeutics, Inc. | 26.68M | 2.76% | 58,804 | - |
| 466 | PTN | Palatin Technologies, Inc. | 25.70M | 3.09% | 9,455 | 12.88M |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 25.63M | 1.55% | 543,106 | 789.00K |
| 468 | CLRB | Cellectar Biosciences, Inc. | 25.57M | 0.95% | 145,595 | - |
| 469 | JSPR | Jasper Therapeutics, Inc. | 25.28M | 3.48% | 680,195 | - |
| 470 | BCTX | BriaCell Therapeutics Corp. | 25.13M | -6.18% | 491,885 | - |
| 471 | CELU | Celularity Inc. | 25.09M | -3.17% | 120,889 | 26.55M |
| 472 | LGVN | Longeveron Inc. | 24.02M | 13.74% | 377,669 | 1.22M |
| 473 | SNSE | Sensei Biotherapeutics, Inc. | 23.87M | 2.51% | 21,119 | - |
| 474 | PLUR | Pluri Inc. | 23.86M | 3.22% | 6,161 | 1.08M |
| 475 | MRKR | Marker Therapeutics, Inc. | 23.34M | -2.10% | 63,234 | 3.55M |
| 476 | TRAW | Traws Pharma, Inc. | 22.57M | - | 787,978 | 2.73M |
| 477 | VYNE | VYNE Therapeutics Inc. | 22.37M | -0.96% | 78,464 | 454.00K |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 21.56M | 5.02% | 619,459 | 1.14M |
| 479 | AKTX | Akari Therapeutics, Plc | 20.91M | 255.45% | 34,042,960 | - |
| 480 | CVM | CEL-SCI Corporation | 20.58M | -2.07% | 276,857 | - |
| 481 | AEON | AEON Biopharma, Inc. | 20.45M | -5.36% | 134,780 | - |
| 482 | CRIS | Curis, Inc. | 20.04M | 2.29% | 105,481 | 7.06M |
| 483 | MTVA | MetaVia Inc. | 19.88M | 34.15% | 40,338,052 | - |
| 484 | HCWB | HCW Biologics Inc. | 19.46M | 12.02% | 20,210,257 | 6.59M |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 19.25M | 4.16% | 433,854 | 5.61M |
| 486 | LPCN | Lipocine Inc. | 18.14M | 1.80% | 61,250 | 2.00M |
| 487 | QNCX | Quince Therapeutics, Inc. | 17.93M | 2.80% | 1,229,399 | - |
| 488 | XCUR | Exicure, Inc. | 17.91M | 1.81% | 15,445 | 500.00K |
| 489 | KTTA | Pasithea Therapeutics Corp. | 17.45M | -2.94% | 334,625 | - |
| 490 | NCEL | NewcelX Ltd. | 17.01M | -0.63% | 11,645 | - |
| 491 | PASG | Passage Bio, Inc. | 16.76M | 1.26% | 10,953 | - |
| 492 | OSRH | OSR Holdings, Inc. | 16.63M | -1.59% | 645,116 | 2.63M |
| 493 | INAB | IN8bio, Inc. | 16.44M | -0.60% | 87,649 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 16.11M | 7.33% | 102,963 | 368.00K |
| 495 | CVKD | Cadrenal Therapeutics, Inc. | 15.98M | 0.39% | 101,659 | - |
| 496 | GTBP | GT Biopharma, Inc. | 15.87M | 1.62% | 2,556,641 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 15.86M | 1.77% | 54,328 | 225.00K |
| 498 | HIND | Vyome Holdings, Inc. | 15.65M | - | 16,629 | 152.72K |
| 499 | ICU | SeaStar Medical Holding Corporation | 14.99M | -5.30% | 137,586 | 1.44M |
| 500 | CMMB | Chemomab Therapeutics Ltd. | 14.54M | 10.99% | 90,466 | - |